Confidential mandate
Director of Clinical Transformation — Interim, Hospital Network
Urgent / Replacement
Following a stalled standardisation programme, a hospital network requires an interim director for nine months to embed common care pathways and transfer an auditable transformation office.
The mandate
A two-year clinical standardisation effort lost its sponsor and has produced presentations rather than adopted practice. Variation in sepsis, joint-replacement and maternity pathways is now visible in outcome and cost data, prompting the board to replace programme leadership immediately.
The director is expected within four weeks for a fixed nine-month intervention; the role then dissolves into the established clinical excellence function. There is no conversion route, and the internal deputy must assume the cadence at the end of month nine.
Success at handover means six priority pathways are live in eight hospitals, at least eighty-five per cent of eligible cases follow the agreed bundles, and finance has validated the first ₹18 crore of annualised benefit without weakening clinical indicators.
The interim can sequence workstreams, assign clinical analysts, approve pathway pilots below ₹40 lakh and stop deployments that fail safety gates. Changes to medical bylaws, executive incentives or technology contracts need the COO; the director may not alter consultant employment terms.
An enterprise EHR replacement, construction of the new Noida facility and procurement-category savings sit outside this mandate. The assignment is about practice adoption and benefits evidence, not an open-ended digital transformation.
Why this seat is open
The former sponsor moved overseas and the programme manager resigned shortly afterwards. Hospital CEOs have since interpreted optional governance as permission to defer difficult pathway decisions. The board has imposed a nine-month recovery window before folding the work into business-as-usual clinical excellence.
What you will own
- Select six pathways using outcome dispersion, avoidable cost and implementation readiness, and document the prioritisation logic.
- Convert each pathway into a signed clinical bundle, exception rule, data definition and site adoption plan.
- Convene specialty councils to resolve contested protocols and record minority clinical opinions before approval.
- Launch two lighthouse hospitals first, measure four-week compliance, and revise deployment kits before wider release.
- Reconcile clinical benefits with finance monthly through case-level sampling rather than forecast-only reporting.
- Escalate site CEOs whose adoption falls below threshold and agree dated recovery actions with the COO.
- Transfer the portfolio, decision log and benefits ledger to the internal deputy through two chaired cycles.
Candidate qualifications
- Eighteen or more years spanning frontline clinical practice, hospital performance improvement and multi-site transformation leadership.
- Demonstrated authorship and implementation of standard care pathways across hospitals with materially different case mixes.
- Ability to interpret risk-adjusted outcomes, episode cost and compliance data well enough to challenge both clinicians and finance.
- Track record securing consultant adoption through evidence, peer comparison and governance rather than positional authority alone.
- Experience building benefits cases that survived finance validation and distinguished cash, capacity and quality outcomes.
- Familiarity with NABH standards, clinical audit design, patient-consent obligations and protected-health-data controls.
Non-negotiables
- Present in Delhi NCR at least four days each week for the full assignment.
- No commercial interest in pathway software or clinical-supply vendors under consideration.
- Prepared to work to a fixed nine-month closure with no assumption of renewal.
- Able to provide two references from chief medical or operating officers who received completed transformations.
- 49 words maximum. When can you begin, and what prevents you from committing four onsite days each week?
- 49 words maximum. Name one pathway adoption rate you moved, including starting point, result and measurement period.
- 49 words maximum. How did you resolve a protocol dispute between respected clinicians without diluting the standard?
This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.